Trond Bruun, M.D., Ph.D. is an Infectious Disease Physician at Haukeland University Hospital in Bergen, Norway. He is also part of Gade Research Group for Infection and Immunity at the Department of Clinical Science, University of Bergen. His main research has been on skin and soft tissue infections, particularly erysipelas, cellulitis and necrotizing fasciitis caused by Streptococcus pyogenes and Streptococcus dysgalactiae. The streptococcal studies of the research group focuses primarily on clinical epidemiology, clinical features and treatment of severe infections in relation to the causative bacteria and their traits. At present, Bruun and other members of the group is working as part of the INFECT study consortium. The INFECT study (www.fp7infect.eu) is a large, prospective, Scandinavian cohort study on necrotizing soft tissue infections (NSTI). Both pathogenetic and clinical analyses are performed, with a particular focus on NSTI caused by Streptococcus pyogenes, Streptococcus dysgalactiae and Staphylococcus aureus. The goal of the study is to elucidate complex host and pathogen signatures that dictate severe bacterial soft tissue infection. In addition, bacterial etiology and diagnostic features are characterized. Furthermore, response and prognosis are described in relation to the treatment given. The ultimate aim is to increase pathogenetic understanding and improve diagnostic methods and treatment of NSTI.
Abstracts this author is presenting: